发明名称 GENETICALLY MODIFIED CELLS AND THEIR USE IN THE PROPHYLAXIS OR THERAPY OF DISORDERS
摘要 The invention provides a method of culturing mononuclear cells, comprising isolating mononuclear cells from the blood or cell-containing fluids of the body of a mammal; culturing the cells in a culture medium comprising one or more of gangliosides, phospholipids, glycolipids and growth factors for endothelial cells. These cells are useful, for example, for the endothelialization of injured vessels. The invention also provides a method of making cells capable of expressing a biologically active protein, comprising isolating mononuclear cells from the blood or cell-containing fluids of the body of a mammal; culturing the cells in a culture medium comprising one or more of gangliosides, phospholipids, glycolipids and growth factors for endothelial cells; optionally, before or after culturing the cells, immortalizing the cells; and transfecting the cells with a nucleic acid construct comprising a gene for the biologically active protein. The cells are useful, for example in gene therapy methods for the prophylaxis or therapy of disorders. Cells obtainable by these methods and obtained by these methods also are provided.
申请公布号 US2002098166(A1) 申请公布日期 2002.07.25
申请号 US19980119659 申请日期 1998.07.21
申请人 HAVEMANN KLAUS;MUELLER DR.ROLF;SEDLACEK DR.HANS-HARALD 发明人 HAVEMANN KLAUS;MUELLER DR.ROLF;SEDLACEK DR.HANS-HARALD
分类号 C12N15/09;A61K31/70;A61K35/12;A61K35/14;A61K35/26;A61K35/28;A61K38/00;A61K38/22;A61K39/00;A61K39/395;A61K48/00;A61P5/00;A61P7/02;A61P7/06;A61P9/00;A61P17/00;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P37/06;A61P37/08;C12N5/02;C12N5/078;C12N5/10;C12N15/06;C12N15/07;C12N15/63;C12N15/86;(IPC1-7):A61K48/00;C12N5/06 主分类号 C12N15/09
代理机构 代理人
主权项
地址